Jury says J&J must pay US$8bil in case over male breast growth


The Philadelphia Court of Common Pleas jury's verdict in favor of Nicholas Murray came in the first case in which a Pennsylvania jury had been able to consider awarding punitive damages in one of thousands of Risperdal cases pending in the state.

NEW YORK: Johnson & Johnson must pay $8 billion in punitive damages to a man who previously won $680,000 over his claims that it failed to warn that young men using its antipsychotic drug Risperdal could grow breasts, a Philadelphia jury said on Tuesday.

The Philadelphia Court of Common Pleas jury's verdict in favor of Nicholas Murray came in the first case in which a Pennsylvania jury had been able to consider awarding punitive damages in one of thousands of Risperdal cases pending in the state.

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Johnson & Johnson , Risperdal , drug , breast , growth , men ,

   

Next In Business News

Wall St set to open higher on tech boost, PCE data
US inflation rises in line with expectations in March
Gamuda Land announces retail partners for Gamuda Gardens
YNH reaffirms bondholders with remedied technical defaults
Ringgit ends firmer against US dollar
KPJ Healthcare partners with Trustr for AI-driven healthcare solutions
Homeritz stays positive amid economic challenges
Unisem expects performance boost amid semiconductor recovery
Gadang wins RM280mil data centre contract
S P Setia unveils Casaville single-storey bungalows in Setia EcoHill, Semenyih

Others Also Read